Answer
Its licence is for additional cardiovascular-risk reduction in eligible adults already treated with a statin, rather than as a replacement.
Sources for this answer
- Vazkepaemc · SmPC Current selected SmPC · Version 4
loading page…
Explore the tools and reference material available on iatroX.
Explore askiatroX